comparison of glp-1 agonists Mapping the effectiveness and risks receptor GLP-1 receptor agonists for individualized

13,14,15 By integrating the latest clinical trial data, we explore the efficacy of GLP-1RAs in treating diseases of the nervous, cardiovascular, endocrine, and digestive systems

Patients using GLP-1RAs should maintain a diet rich in healthy proteins and whole foods while avoiding ultra-processed foods, especially in those with frailty

K., Jalewa, J

Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice

Despite strong clinical evidence supporting the effectiveness of GLP-1 therapies for weight loss, coverage remains inconsistent and often restrictive

Because of its proven results, semaglutide has been approved under several brand names for weight loss in adults who are overweight or have obesityeven in those who do not have diabetes